Prof. Dr. Zsuzsanna Helyes

MD, clinical laboratory diagnostics and clinical pharmacology specialist, PhD and corresponding member of the Hungarian Academy of Sciences, full professor of pharmacology at the Department of Pharmacology and Pharmacotherapy of the University of Pecs Medical School. Her main field of research is neuropharmacology, with the main focus on sensory pharmacology, the role of capsaicin-sensitive peptidergic afferents and neuro-vascular-immune interactions in inflammatory and pain processes both at the periphery and the central nervous system. They put special emphasis on characterizing the links between sensory nerves, neuropeptides, enzymes, and immune cell-derived amine, lipid and glycoprotein mediators, and TRP channels. Her team identifies novel targets for analgesic and anti-inflammatory drug development. She supervised 23 defended PhDs, published 243 papers (total number of citations: 8012) and 12 patents, her h-index 50 (Google Scholar). She is the founder and strategic director of PharmInVivo Ltd. (Hungary), the founder and stakeholder of Algonist Gmbh (Austria), and a scientific advisor of Pharmnovo Ltd (Sweden). She is an editor of Brain Research Bulletin, Scientific Reports and Frontiers in Pharmacology, as well as a steering committee member of the Hungarian Pain Society and Physiology Society, as well as the secretary general of the Hungarian Society of Experimental and Clinical Pharmacology.